NCT00202904View on ClinicalTrials.gov

Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
HypercholesterolemiaCoronary Heart Disease
Interventions
DRUG

ezetimibe

ezetimibe 10 mg tablets, one tablet taken daily with atorvastatin 10 mg daily for 6 weeks

DRUG

placebo

placebo tablets matched to ezetimibe, one tablet taken daily with atorvastatin 10 mg daily for 6 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00202904 - Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740) | Biotech Hunter | Biotech Hunter